Inflammation in Viral Vector-Mediated Ocular Gene Therapy: A Review and Report From a Workshop Hosted by the Foundation Fighting Blindness, 9/2020

Ocular Gene Therapy Inflammation Working Group

doi:10.1167/tvst.10.4.3

Inflammation in Viral Vector-Mediated Ocular Gene Therapy: A Review and Report From a Workshop Hosted by the Foundation Fighting Blindness, 9/2020

Ocular Gene Therapy Inflammation Working Group

Research output: Contribution to journal › Article (Academic Journal) › peer-review

1 Citation (Scopus)

Abstract

Translational Relevance: Subclinical or clinical inflammation often arises during ocular gene therapy with viral vectors. Understanding the biological bases and impacts on efficacy are important for clinical management and the improvement of future therapies.

Original language	English
Article number	3
Pages (from-to)	3
Journal	Translational vision science & technology
Volume	10
Issue number	4
DOIs	https://doi.org/10.1167/tvst.10.4.3
Publication status	Published - 1 Apr 2021

Bibliographical note

Publisher Copyright:
© 2021 by the authors.

Access to Document

10.1167/tvst.10.4.3Licence: CC BY

Full-text PDF (final published version)
This is the final published version of the article (version of record). It first appeared online via ARVO Journals at https://doi.org/10.1167/tvst.10.4.3 . Please refer to any applicable terms of use of the publisher.
Final published version, 417 KBLicence: CC BY

Cite this

@article{0cb54acc67fb40c98c75b9aab11d219e,

title = "Inflammation in Viral Vector-Mediated Ocular Gene Therapy: A Review and Report From a Workshop Hosted by the Foundation Fighting Blindness, 9/2020",

abstract = "Translational Relevance: Subclinical or clinical inflammation often arises during ocular gene therapy with viral vectors. Understanding the biological bases and impacts on efficacy are important for clinical management and the improvement of future therapies.",

author = "{Ocular Gene Therapy Inflammation Working Group} and Chan, {Ying Kai} and Dick, {Andrew D} and Hall, {Sara Mary} and Thomas Langmann and Scribner, {Curtis L} and Mansfield, {Brian C}",

note = "Publisher Copyright: {\textcopyright} 2021 by the authors.",

year = "2021",

month = apr,

day = "1",

doi = "10.1167/tvst.10.4.3",

language = "English",

volume = "10",

pages = "3",

journal = "Translational vision science & technology",

issn = "2164-2591",

publisher = "Association for Research in Vision and Ophthalmology",

number = "4",

}

TY - JOUR

T1 - Inflammation in Viral Vector-Mediated Ocular Gene Therapy

T2 - A Review and Report From a Workshop Hosted by the Foundation Fighting Blindness, 9/2020

AU - Ocular Gene Therapy Inflammation Working Group

AU - Chan, Ying Kai

AU - Dick, Andrew D

AU - Hall, Sara Mary

AU - Langmann, Thomas

AU - Scribner, Curtis L

AU - Mansfield, Brian C

PY - 2021/4/1

Y1 - 2021/4/1

N2 - Translational Relevance: Subclinical or clinical inflammation often arises during ocular gene therapy with viral vectors. Understanding the biological bases and impacts on efficacy are important for clinical management and the improvement of future therapies.

AB - Translational Relevance: Subclinical or clinical inflammation often arises during ocular gene therapy with viral vectors. Understanding the biological bases and impacts on efficacy are important for clinical management and the improvement of future therapies.

U2 - 10.1167/tvst.10.4.3

DO - 10.1167/tvst.10.4.3

M3 - Article (Academic Journal)

C2 - 34003982

VL - 10

SP - 3

JO - Translational vision science & technology

JF - Translational vision science & technology

SN - 2164-2591

IS - 4

M1 - 3

ER -

Inflammation in Viral Vector-Mediated Ocular Gene Therapy: A Review and Report From a Workshop Hosted by the Foundation Fighting Blindness, 9/2020

Abstract

Bibliographical note

Access to Document

Fingerprint

Cite this